Inventor · disambiguated record
Yongcheng Song
Also filed as: SONG YONGCHENG
13 granted patents·9 pending applications·49 citations·filing 2001–2025
89Inventor score
Top patents by PatentIndex Score
22 records- 0192US11708350B2Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agentsBAYLOR COLLEGE MEDICINE·Filed 2020·Granted Jul 25, 2023·2 cites·15 claims
- 0291US10875841B2Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agentsBAYLOR COLLEGE MEDICINE·Filed 2019·Granted Dec 29, 2020·4 cites·8 claims
- 0388US7745422B2Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseasesUNIV ILLINOIS·Filed 2008·Granted Jun 29, 2010·11 cites·27 claims
- 0487US7358361B2Biophosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseasesUNIV ILLINOIS·Filed 2005·Granted Apr 15, 2008·10 cites·12 claims
- 0584US12338229B2Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agentsBAYLOR COLLEGE MEDICINE·Filed 2023·Granted Jun 24, 2025·0 cites·13 claims
- 0682US7687482B2Bisphosphonate compounds and methodsUNIV ILLINOIS·Filed 2007·Granted Mar 30, 2010·6 cites·19 claims
- 0781US8071573B2Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseasesSANDERS JOHN M·Filed 2010·Granted Dec 6, 2011·5 cites·39 claims
- 0881US2025282755A1Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agentsBAYLOR COLLEGE MEDICINE·Filed 2025·Application pending·0 cites
- 0980US9636323B2Method of treating cancer that overexpresses TopBP1LIN WEEI-CHIN·Filed 2015·Granted May 2, 2017·9 cites·3 claims
- 1069US11312676B2Small molecule stimulators of steroid receptor coactivator proteins and their use in the treatment of cancerBAYLOR COLLEGE MEDICINE·Filed 2015·Granted Apr 26, 2022·1 cites·7 claims
- 1163US2025235437A1Proteolysis targeting chimera (protac) molecule for degradation of enl and cancer therapyBAYLOR COLLEGE MEDICINE·Filed 2023·Application pending·0 cites
- 1254US11344600B2Structure of GII.4 norovirus protease—design of broad-spectrum protease inhibitorsBAYLOR COLLEGE MEDICINE·Filed 2017·Granted May 31, 2022·0 cites·7 claims
- 1352US6774254B2Gold complexesUNIV SINGAPORE·Filed 2001·Granted Aug 10, 2004·1 cites·151 claims
- 1449US8148352B2Antimicrobial therapy for bacterial infectionsNIZET VICTOR·Filed 2007·Granted Apr 3, 2012·0 cites·14 claims
- 1549US2023167101A1Novel inhibitors of histone acetyltransferase p300/cbp for cancer therapyBAYLOR COLLEGE MEDICINE·Filed 2021·Application pending·0 cites
- 1649US2015065466A1Novel dxr inhibitors for antimicrobial therapyBAYLOR COLLEGE MEDICINE·Filed 2013·Application pending·0 cites
- 1743US8778913B2Antimicrobial compositions for treating microbial infectionsNIZET VICTOR·Filed 2012·Granted Jul 15, 2014·0 cites·22 claims
- 1840US2016168185A1Non-ribose containing inhibitors of histone methyltransferase dot1l for cancer treatmentBAYLOR COLLEGE MEDICINE·Filed 2014·Application pending·0 cites
- 1937US2014100184A1Selective inhibitors of histone methyltransferase dot1lBAYLOR COLLEGE MEDICINE·Filed 2013·Application pending·0 cites
- 2036US2012329842A1Small molecule compounds as broad-spectrum inhibitors of metallo-beta-lactamasesSONG YONGCHENG·Filed 2011·Application pending·0 cites
- 2136US2013065857A1Novel dxr inhibitors for antimicrobial therapySONG YONGCHENG·Filed 2010·Application pending·0 cites
- 2231US2012022024A1Anti-bacterial compositions and methods including targeting virulence factors of staphylococcus aureusOLDFIELD ERIC·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yongcheng Song files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →